| Year |
Citation |
Score |
| 2024 |
Cong K, MacGilvary N, Lee S, MacLeod SG, Calvo J, Peng M, Nedergaard Kousholt A, Day TA, Cantor SB. FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. Nature Communications. 15: 2599. PMID 38521768 DOI: 10.1038/s41467-024-46824-5 |
0.518 |
|
| 2024 |
Cong K, MacGilvary N, Lee S, MacLeod SG, Calvo J, Peng M, Kousholt AN, Day T, Cantor SB. FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. Biorxiv : the Preprint Server For Biology. PMID 38260529 DOI: 10.1101/2024.01.04.574095 |
0.511 |
|
| 2023 |
Shalwitz R, Day T, Kotsakis Ruehlmann A, Julio L, Gordon S, Vandeuren A, Nelson M, Lyman M, Kelly K, Altvater A, Ondeck C, O'Brien S, Hamilton T, Hanson RL, Wayman K, et al. Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel Approach. The Journal of Pharmacology and Experimental Therapeutics. PMID 37977813 DOI: 10.1124/jpet.123.001686 |
0.337 |
|
| 2022 |
Durando ML, Menghani SV, Baumann JL, Robles DG, Day TA, Vaziri C, Scott AJ. Four-Year Disease-Free Remission in a Patient With POLE Mutation-Associated Colorectal Cancer Treated Using Anti-PD-1 Therapy. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 218-223. PMID 35276675 DOI: 10.6004/jnccn.2021.7115 |
0.607 |
|
| 2021 |
Vaziri C, Rogozin IB, Gu Q, Wu D, Day TA. Unravelling roles of error-prone DNA polymerases in shaping cancer genomes. Oncogene. PMID 34663880 DOI: 10.1038/s41388-021-02032-9 |
0.707 |
|
| 2020 |
Layer JV, Debaize L, Van Scoyk A, House NC, Brown AJ, Liu Y, Stevenson KE, Hemann M, Roberts SA, Price BD, Weinstock DM, Day TA. Polymerase δ promotes chromosomal rearrangements and imprecise double-strand break repair. Proceedings of the National Academy of Sciences of the United States of America. PMID 33077594 DOI: 10.1073/pnas.2014176117 |
0.496 |
|
| 2019 |
Qi H, Price BD, Day TA. Multiple Roles for Mono- and Poly(ADP-Ribose) in Regulating Stress Responses. Trends in Genetics : Tig. 35: 159-172. PMID 30595401 DOI: 10.1016/J.Tig.2018.12.002 |
0.337 |
|
| 2018 |
Layer JV, Cleary JP, Brown AJ, Stevenson KE, Morrow SN, Van Scoyk A, Blasco RB, Karaca E, Meng FL, Frock RL, Tivey T, Kim S, Fuchs H, Chiarle R, Alt FW, ... ... Day TA, et al. Parp3 promotes long-range end joining in murine cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 30213852 DOI: 10.1073/Pnas.1801591115 |
0.466 |
|
| 2017 |
Day TA, Layer JV, Cleary JP, Guha S, Stevenson KE, Tivey T, Kim S, Schinzel AC, Izzo F, Doench J, Root DE, Hahn WC, Price BD, Weinstock DM. Corrigendum: PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. Nature Communications. 8: 15918. PMID 28607496 DOI: 10.1038/Ncomms15918 |
0.462 |
|
| 2017 |
Day TA, Layer JV, Cleary JP, Guha S, Stevenson KE, Tivey T, Kim S, Schinzel AC, Izzo F, Doench J, Root DE, Hahn WC, Price BD, Weinstock DM. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. Nature Communications. 8: 15110. PMID 28447610 DOI: 10.1038/Ncomms15110 |
0.6 |
|
| 2016 |
Choi YE, Meghani K, Brault ME, Leclerc L, He YJ, Day TA, Elias KM, Drapkin R, Weinstock DM, Dao F, Shih KK, Matulonis U, Levine DA, Konstantinopoulos PA, Chowdhury D. Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer. Cell Reports. PMID 26774475 DOI: 10.1016/J.Celrep.2015.12.046 |
0.366 |
|
| 2014 |
Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend E, Bodegom Dv, Day TA, Wu S, Liu H, Yoda A, Alexe G, Schinzel A, Sullivan TJ, Malinge S, et al. Abstract 433: Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 Cancer Research. 74: 433-433. DOI: 10.1158/1538-7445.Am2014-433 |
0.321 |
|
| 2012 |
Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, Fung H, Brown JR, Shapiro GI, Letai A, Weinstock DM. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Research. 72: 4193-203. PMID 22689920 DOI: 10.1158/0008-5472.Can-11-4204 |
0.417 |
|
| 2012 |
Barkley LR, Palle K, Durando M, Day TA, Gurkar A, Kakusho N, Li J, Masai H, Vaziri C. c-Jun N-terminal kinase-mediated Rad18 phosphorylation facilitates Polη recruitment to stalled replication forks. Molecular Biology of the Cell. 23: 1943-54. PMID 22456510 DOI: 10.1091/Mbc.E11-10-0829 |
0.708 |
|
| 2011 |
Day TA, Sproul C, Cordeiro-Stone M, Vaziri C. Analyzing DNA replication dynamics of genotoxin-treated cells using velocity sedimentation. Methods in Molecular Biology (Clifton, N.J.). 782: 159-70. PMID 21870290 DOI: 10.1007/978-1-61779-273-1_11 |
0.746 |
|
| 2010 |
Day TA, Palle K, Barkley LR, Kakusho N, Zou Y, Tateishi S, Verreault A, Masai H, Vaziri C. Phosphorylated Rad18 directs DNA polymerase η to sites of stalled replication. The Journal of Cell Biology. 191: 953-66. PMID 21098111 DOI: 10.1083/Jcb.201006043 |
0.757 |
|
| 2010 |
Song IY, Barkley LR, Day TA, Weiss RS, Vaziri C. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells. Cell Cycle (Georgetown, Tex.). 9: 2375-88. PMID 20519958 DOI: 10.4161/Cc.9.12.11900 |
0.712 |
|
| 2009 |
Day T, Vaziri C. HPV E6 oncoprotein prevents recovery of stalled replication forks independently of p53 degradation. Cell Cycle (Georgetown, Tex.). 8: 2138. PMID 19587541 DOI: 10.4161/Cc.8.14.9028 |
0.572 |
|
| 2006 |
Liu P, Barkley LR, Day T, Bi X, Slater DM, Alexandrow MG, Nasheuer HP, Vaziri C. The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism. The Journal of Biological Chemistry. 281: 30631-44. PMID 16912045 DOI: 10.1074/Jbc.M602982200 |
0.736 |
|
| Show low-probability matches. |